NEW YORK (GenomeWeb News) – The Lustgarten Foundation for Pancreatic Cancer said today it plans to launch a $1.25 million project to develop antibodies for biomarker targets for pancreatic cancer, the Foundation said today.
 
The Pancreatic Cancer Biomarker Development Project is a consortium of four research organizations including Canary Foundation, Dana-Farber Cancer Institute, University of California at San Francisco and Van Andel Research Institute.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.